\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\ demonstrated\\ a\\ large\\ \\(1\\.5\\ x\\ 1\\.5\\ cm\\)\\ immobile\\ mass\\ at\\ the\\ left\\ medial\\ canthus\\ just\\ below\\ the\\ lower\\ eyelid\\ with\\ overlying\\ mild\\ erythema\\ but\\ no\\ discharge\\ and\\ no\\ significant\\ tenderness\\ on\\ palpation\\.\ \(0\)\
\-\ urgent\\ surgery\\ was\\ determined\\ to\\ be\\ necessary\\ and\\ patient\\ underwent\\ medial\\ maxillectomy\\ and\\ orbital\\ exenteration\\.\\ post\\-surgical\\ pathology\\ reports\\ indicated\\ the\\ deep\\ margins\\ were\\ positive\\.\\ though\\ ent\\ was\\ skeptical\\ these\\ were\\ true\\ margins\\ adjuvant\\ radiation\\ therapy\\ was\\ opted\\ for\\ to\\ provide\\ assurance\\ of\\ thorough\\ eradication\\.\\ patient\\ completed\\ his\\ course\\ of\\ radiation\\ therapy\\ and\\ was\\ disease\\ free\\ at\\ month\\ 5\\.\ \(0\)\
\-\ ct\\ and\\ mri\\ demonstrated\\ a\\ fungating\\ mass\\ occupying\\ the\\ entire\\ left\\ nasolacrimal\\ duct\\ displacing\\ the\\ left\\ orbit\\ to\\ a\\ significant\\ degree\\.\ \(0\)\
\-\ non\\-keratinizing\\ squamous\\ cell\\ carcinoma\ \(1\)\
\-\ dacryocystitis\\,\\ chronic\\ inflammation\\,\\ nodulocystic\\ acne\\,\\ malignancy\\,\\ chalazion\\,\\ dermoid\\ cyst\\,\\ blepharitis\\.\ \(0\)\
\-\ a\\ 31\\ yo\\ man\\ presented\\ to\\ his\\ primary\\ care\\ doctor\\ complaining\\ of\\ a\\ growing\\ bump\\ under\\ his\\ left\\ eye\\.\\ he\\ was\\ prescribed\\ a\\ course\\ of\\ antibiotics\\ and\\ referred\\ to\\ dermatology\\.\\ after\\ being\\ examined\\ by\\ dermatology\\ 2\\ weeks\\ later\\,\\ patient\\ was\\ sent\\ to\\ ophthalmology\\ with\\ concerns\\ for\\ dacryocystitis\\.\\ ophthalmology\\ ordered\\ a\\ ct\\ scan\\ for\\ further\\ evaluation\\.\\ the\\ extent\\ of\\ involvement\\ and\\ the\\ characteristics\\ of\\ the\\ mass\\ on\\ ct\\ made\\ ophthalmology\\ concerned\\ for\\ a\\ malignancy\\ so\\ patient\\ was\\ referred\\ to\\ otolaryngology\\.\ \(0\)\
\-\ squamous\\ cell\\ carcinoma\\ \\(scc\\)\\ is\\ the\\ most\\ frequently\\ diagnosed\\ malignant\\ tumor\\ of\\ the\\ head\\ and\\ neck\\,\\ and\\ has\\ the\\ sixth\\ highest\\ incidence\\ for\\ cancers\\ worldwide\\.\\ it\\ is\\ most\\ often\\ diagnosed\\ during\\ the\\ sixth\\ and\\ seventh\\ decade\\ in\\ patients\\ with\\ specific\\ risk\\ factors\\,\\ including\\ tobacco\\ use\\ and\\ alcohol\\ consumption\\.\\ scc\\ is\\ also\\ commonly\\ associated\\ with\\ human\\ papilloma\\ virus\\ \\(hpv\\)\\ infection\\.\\ the\\ majority\\ of\\ cases\\ of\\ scc\\ arise\\ from\\ preneoplastic\\ lesions\\ with\\ dysplastic\\ cytologic\\ architecture\\ most\\ commonly\\ affecting\\ the\\ pharynx\\,\\ oropharynx\\ and\\ trachea\\.\\ uncommonly\\ though\\,\\ scc\\ can\\ arise\\ from\\ normal\\ mucosa\\,\\ in\\ young\\ patients\\,\\ with\\ few\\ risk\\ factors\\ and\\ in\\ difficult\\ to\\ visualize\\ places\\,\\ as\\ the\\ following\\ case\\ demonstrates\\.\\ \ \(0\)\
\-\ a\\ 31\\ year\\ old\\ active\\ duty\\ male\\ presented\\ with\\ a\\ chief\\ complaint\\ of\\ a\\ bump\\ beneath\\ his\\ left\\ eye\\ for\\ the\\ past\\ two\\ months\\.\\ he\\ reported\\ intermittent\\ yellow\\ discharge\\ at\\ the\\ corner\\ near\\ his\\ nose\\,\\ increased\\ tearing\\,\\ and\\ increased\\ pain\\,\\ especially\\ to\\ palpation\\,\\ over\\ the\\ previous\\ two\\ weeks\\.\\ review\\ of\\ all\\ other\\ systems\\ was\\ negative\\.\\ he\\ had\\ no\\ significant\\ past\\ medical\\ history\\,\\ denied\\ any\\ previous\\ surgeries\\ and\\ his\\ social\\ history\\ was\\ negative\\ for\\ tobacco\\ or\\ alcohol\\ abuse\\.\\ his\\ family\\ history\\ was\\ unobtainable\\ because\\ the\\ patient\\ was\\ adopted\\.\\ initial\\ physical\\ exam\\ was\\ significant\\ for\\ a\\ firm\\,\\ palpable\\ lump\\ just\\ below\\ the\\ left\\ lower\\ eyelid\\.\\ the\\ lesion\\ was\\ 1\\ cm\\ x\\ 1\\ cm\\ in\\ size\\,\\ skin\\-toned\\,\\ non\\-erythematous\\,\\ non\\-purulent\\,\\ and\\ mildly\\ tender\\ to\\ palpation\\.\\ the\\ patient\\ was\\ prescribed\\ a\\ course\\ of\\ antibiotics\\ and\\ referred\\ to\\ dermatology\\.\\ at\\ his\\ appointment\\ with\\ dermatology\\ three\\ weeks\\ later\\,\\ his\\ symptoms\\ were\\ worse\\ and\\ the\\ lesion\\ had\\ grown\\ in\\ size\\.\\ he\\ was\\ sent\\ to\\ ophthalmology\\.\\ a\\ ct\\ scan\\ was\\ ordered\\,\\ which\\ showed\\ a\\ fungating\\ mass\\ within\\ the\\ left\\ lacrimal\\ sac\\ suspicious\\ for\\ malignancy\\.\\ \\ he\\ was\\ referred\\ to\\ otolaryngology\\.\\ \\ the\\ patient\\ had\\ an\\ unremarkable\\ nasal\\ endoscopy\\,\\ as\\ well\\ as\\ multiple\\ biopsies\\ by\\ fine\\ needle\\ aspiration\\ and\\ direct\\ excision\\.\\ results\\ from\\ tissue\\ examination\\ by\\ pathology\\ revealed\\ non\\-keratinizing\\ squamous\\ cell\\ carcinoma\\ in\\ situ\\:\\ a\\ malignant\\ neoplasm\\.\\ \\ the\\ patient\\ was\\ managed\\ with\\ surgery\\ combined\\ with\\ radiation\\ therapy\\.\\ in\\ order\\ to\\ debulk\\ the\\ entire\\ tumor\\ and\\ attain\\ clear\\ margins\\,\\ enucleation\\ of\\ the\\ left\\ eye\\ was\\ required\\.\\ currently\\,\\ the\\ patient\\ has\\ numerous\\ reconstructive\\ surgeries\\ planned\\,\\ but\\ is\\ doing\\ well\\ overall\\ with\\ no\\ sign\\ of\\ metastasis\\ or\\ recurrence\\.\\ \ \(0\)\
\-\ this\\ case\\ exemplifies\\ the\\ importance\\ of\\ early\\ recognition\\ of\\ scc\\ and\\ proper\\ use\\ of\\ multidisciplinary\\ consultation\\ e\\.g\\.\\ dermatology\\,\\ ent\\,\\ ophthalmology\\ and\\ pathology\\ for\\ management\\ of\\ this\\ disease\\.\\ \\ clinicians\\ should\\ be\\ aware\\ that\\ painful\\,\\ non\\-healing\\ lesions\\,\\ especially\\ those\\ with\\ obstructive\\ characteristics\\ \\(which\\ might\\ indicate\\ a\\ space\\ occupying\\ neoplasm\\,\\ as\\ in\\ this\\ patient\\?s\\ case\\)\\,\\ may\\ represent\\ an\\ insidious\\ process\\ that\\ requires\\ thorough\\ evaluation\\.\\ scc\\ can\\ present\\ in\\ patients\\ from\\ any\\ demographic\\,\\ without\\ any\\ risk\\ factors\\,\\ and\\ who\\ are\\ otherwise\\ healthy\\ individuals\\.\\ \\ although\\ this\\ patient\\ did\\ require\\ enucleation\\ of\\ his\\ left\\ eye\\,\\ multiple\\ surgical\\ revisions\\,\\ radiation\\ therapy\\ and\\ close\\ follow\\-up\\,\\ his\\ prognosis\\ is\\ good\\.\\ \\ attentive\\ evaluation\\ spared\\ him\\ from\\ cns\\ extension\\ and\\ metastasis\\ and\\ reduced\\ the\\ morbidity\\ and\\ mortality\\ associated\\ with\\ this\\ subtle\\ presentation\\ of\\ scc\\.\\ \\ \\ \ \(0\)\
\-\ references\ \(24\)\
\-\ 1\\.\\ lewis\\,\\ james\\ s\\.\\,\\ rebecca\\ d\\.\\ chernock\\,\\ xiao\\-jun\\ ma\\,\\ et\\ al\\.\\ \\"partial\\ p16\\ staining\\ in\\ oropharyngeal\\ squamous\\ cell\\ carcinoma\\:\\ extent\\ and\\ pattern\\ correlate\\ with\\ human\\ papillomavirus\\ rna\\ status\\.\\"\\ modern\\ pathology\\ 25\\.9\\ \\(2012\\)\\:\\ 1212\\-220\\.\\ web\\.\\ 06\\ feb\\.\\ 2017\\.\ \(0\)\
\-\ 2\\.\\ lim\\,\\ jae\\ h\\.\\,\\ shaolei\\ lu\\,\\ calvin\\ e\\.\\ oyer\\,\\ and\\ ronald\\ a\\.\\ delellis\\.\\ \\"squamous\\ cell\\ carcinoma\\ \\-\\ sinonasal\\.\\"\\ squamous\\ cell\\ carcinoma\\ \\-\\ sinonasal\\.\\ brown\\ medical\\ school\\,\\ 2005\\.\\ web\\.\\ 24\\ feb\\.\\ 2017\\.\ \(0\)\
\-\ 3\\.\\ lim\\,\\ jean\\ lee\\,\\ md\\,\\ and\\ maryam\\ asgari\\,\\ md\\.\\ \\"clinical\\ features\\ and\\ diagnosis\\ of\\ cutaneous\\ squamous\\ cell\\ carcinoma\\ \\(scc\\)\\.\\"\\ uptodate\\:\\ clinical\\ features\\ and\\ diagnosis\\ of\\ cutaneous\\ squamous\\ cell\\ carcinoma\\ \\(scc\\)\\.\\ n\\.p\\.\\,\\ 16\\ mar\\.\\ 2016\\.\\ web\\.\\ 09\\ feb\\.\\ 2017\\.\ \(0\)\
\-\ 4\\.\\ rousseau\\,\\ a\\.\\,\\ and\\ c\\.\\ badoual\\.\\ \\"head\\ and\\ neck\\:\\ squamous\\ cell\\ carcinoma\\:\\ an\\ overview\\.\\"\\ atlas\\ of\\ genetics\\ and\\ cytogenetics\\ in\\ oncology\\ and\\ haematology\\ 2\\ \\(2012\\)\\:\\ web\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ scc\\:\\ 0\\.3086033772772651\ \(0\)\
\-\ squamous\\:\\ 0\\.22688678516752583\ \(0\)\
\-\ and\\:\\ 0\\.20838646775489286\ \(0\)\
\-\ his\\:\\ 0\\.1868803167174108\ \(0\)\
\-\ was\\:\\ 0\\.18549237178585304\ \(0\)\
\-\ the\\:\\ 0\\.17327695194198897\ \(0\)\
\-\ ophthalmology\\:\\ 0\\.16511561585310314\ \(0\)\
\-\ carcinoma\\:\\ 0\\.15080419957833482\ \(0\)\
\-\ cell\\:\\ 0\\.1442217798640692\ \(0\)\
\-\ dermatology\\:\\ 0\\.13704895898862546\ \(0\)\
\-\ of\\:\\ 0\\.12608579825468866\ \(0\)\
\-\ web\\:\\ 0\\.12084643891013323\ \(0\)\
\-\ 2017\\:\\ 0\\.10202571594556575\ \(0\)\
\-\ patient\\:\\ 0\\.10022292077934195\ \(0\)\
\-\ to\\:\\ 0\\.09804421312244496\ \(0\)\
\-\ feb\\:\\ 0\\.09660827400266346\ \(0\)\
\-\ eye\\:\\ 0\\.08963920891017878\ \(0\)\
\-\ pathology\\:\\ 0\\.0879643465308974\ \(0\)\
\-\ left\\:\\ 0\\.08600215429823559\ \(0\)\
\-\ dacryocystitis\\:\\ 0\\.0856150023346375\ \(0\)\
\-\ for\\:\\ 0\\.0849048057984399\ \(0\)\
\-\ he\\:\\ 0\\.08294092184700116\ \(0\)\
\-\ referred\\:\\ 0\\.0829126647776729\ \(0\)\
\-\ otolaryngology\\:\\ 0\\.08278951796923753\ \(0\)\
\-\ lim\\:\\ 0\\.08059790202979174\ \(0\)\
\-\ with\\:\\ 0\\.07679373403684422\ \(0\)\
\-\ in\\:\\ 0\\.07665557405668866\ \(0\)\
\-\ fungating\\:\\ 0\\.07598173705712856\ \(0\)\
\-\ radiation\\:\\ 0\\.07425457299839486\ \(0\)\
\-\ sinonasal\\:\\ 0\\.07379012111768275\ \(0\)\
\-\ margins\\:\\ 0\\.07170086756335968\ \(0\)\
\-\ factors\\:\\ 0\\.07108693174625937\ \(0\)\
\-\ thorough\\:\\ 0\\.06980782457097373\ \(0\)\
\-\ eyelid\\:\\ 0\\.06857852828383669\ \(0\)\
\-\ human\\:\\ 0\\.06857852828383669\ \(0\)\
\-\ bump\\:\\ 0\\.06698234020557378\ \(0\)\
\-\ enucleation\\:\\ 0\\.06698234020557378\ \(0\)\
\-\ sixth\\:\\ 0\\.06479072426612799\ \(0\)\
\-\ significant\\:\\ 0\\.06469601556769197\ \(0\)\
\-\ therapy\\:\\ 0\\.06438080218264826\ \(0\)\
\-\ malignancy\\:\\ 0\\.06291424874487547\ \(0\)\
\-\ course\\:\\ 0\\.06207536973136005\ \(0\)\
\-\ 2012\\:\\ 0\\.061209363051601524\ \(0\)\
\-\ occupying\\:\\ 0\\.06094026260840484\ \(0\)\
\-\ risk\\:\\ 0\\.06004710991051559\ \(0\)\
\-\ ent\\:\\ 0\\.05969536417062955\ \(0\)\
\-\ tobacco\\:\\ 0\\.059464258172344825\ \(0\)\
\-\ surgeries\\:\\ 0\\.059464258172344825\ \(0\)\
\-\ prescribed\\:\\ 0\\.059017747112155725\ \(0\)\
\-\ cutaneous\\:\\ 0\\.05818136528965759\ \(0\)\
\-\ palpation\\:\\ 0\\.05667466431697408\ \(0\)\
\-\ from\\:\\ 0\\.055627586804864196\ \(0\)\
\-\ any\\:\\ 0\\.05431244386107401\ \(0\)\
\-\ sent\\:\\ 0\\.052430684517023284\ \(0\)\
\-\ alcohol\\:\\ 0\\.05178287492228214\ \(0\)\
\-\ characteristics\\:\\ 0\\.0513735843775486\ \(0\)\
\-\ extent\\:\\ 0\\.05127387233571421\ \(0\)\
\-\ arise\\:\\ 0\\.05127387233571421\ \(0\)\
\-\ evaluation\\:\\ 0\\.05125142680844157\ \(0\)\
\-\ md\\:\\ 0\\.051077434752392986\ \(0\)\
\-\ entire\\:\\ 0\\.050980669912909705\ \(0\)\
\-\ weeks\\:\\ 0\\.05036595610647455\ \(0\)\
\-\ discharge\\:\\ 0\\.050239068577577484\ \(0\)\
\-\ 31\\:\\ 0\\.049717447679219845\ \(0\)\
\-\ ordered\\:\\ 0\\.04922213843995386\ \(0\)\
\-\ though\\:\\ 0\\.048674180713526825\ \(0\)\
\-\ cm\\:\\ 0\\.04826429674875841\ \(0\)\
\-\ this\\:\\ 0\\.04812860281411275\ \(0\)\
\-\ patients\\:\\ 0\\.047276284530784675\ \(0\)\
\-\ below\\:\\ 0\\.04613843865049349\ \(0\)\
\-\ features\\:\\ 0\\.045080138345836\ \(0\)\
\-\ as\\:\\ 0\\.04501502802088235\ \(0\)\
\-\ just\\:\\ 0\\.04481960445508939\ \(0\)\
\-\ maxillectomy\\:\\ 0\\.04479864944067326\ \(0\)\
\-\ skeptical\\:\\ 0\\.04479864944067326\ \(0\)\
\-\ nodulocystic\\:\\ 0\\.04479864944067326\ \(0\)\
\-\ blepharitis\\:\\ 0\\.04479864944067326\ \(0\)\
\-\ preneoplastic\\:\\ 0\\.04479864944067326\ \(0\)\
\-\ unobtainable\\:\\ 0\\.04479864944067326\ \(0\)\
\-\ debulk\\:\\ 0\\.04479864944067326\ \(0\)\
\-\ lewis\\:\\ 0\\.04479864944067326\ \(0\)\
\-\ rebecca\\:\\ 0\\.04479864944067326\ \(0\)\
\-\ chernock\\:\\ 0\\.04479864944067326\ \(0\)\
\-\ p16\\:\\ 0\\.04479864944067326\ \(0\)\
\-\ papillomavirus\\:\\ 0\\.04479864944067326\ \(0\)\
\-\ rna\\:\\ 0\\.04479864944067326\ \(0\)\
\-\ jae\\:\\ 0\\.04479864944067326\ \(0\)\
\-\ shaolei\\:\\ 0\\.04479864944067326\ \(0\)\
\-\ calvin\\:\\ 0\\.04479864944067326\ \(0\)\
\-\ oyer\\:\\ 0\\.04479864944067326\ \(0\)\
\-\ delellis\\:\\ 0\\.04479864944067326\ \(0\)\
\-\ maryam\\:\\ 0\\.04479864944067326\ \(0\)\
\-\ asgari\\:\\ 0\\.04479864944067326\ \(0\)\
\-\ badoual\\:\\ 0\\.04479864944067326\ \(0\)\
\-\ especially\\:\\ 0\\.04431839613268844\ \(0\)\
\-\ most\\:\\ 0\\.04373621001141218\ \(0\)\
\-\ were\\:\\ 0\\.043319447965377005\ \(0\)\
\-\ use\\:\\ 0\\.04286742346860616\ \(0\)\
\-\ assurance\\:\\ 0\\.04280750116731875\ \(0\)\
\-\ chalazion\\:\\ 0\\.04280750116731875\ \(0\)\
\-\ attain\\:\\ 0\\.04280750116731875\ \(0\)\
\-\ attentive\\:\\ 0\\.04280750116731875\ \(0\)\
\-\ lu\\:\\ 0\\.04280750116731875\ \(0\)\
\-\ ronald\\:\\ 0\\.04280750116731875\ \(0\)\
\-\ jean\\:\\ 0\\.04280750116731875\ \(0\)\
\-\ rousseau\\:\\ 0\\.04280750116731875\ \(0\)\
\-\ cytogenetics\\:\\ 0\\.04280750116731875\ \(0\)\
\-\ haematology\\:\\ 0\\.04280750116731875\ \(0\)\
\-\ mass\\:\\ 0\\.04280064726501224\ \(0\)\
\-\ ct\\:\\ 0\\.04265902369894971\ \(0\)\
\-\ previous\\:\\ 0\\.042334181149858305\ \(0\)\
\-\ at\\:\\ 0\\.04232323597481081\ \(0\)\
\-\ case\\:\\ 0\\.042220057329984295\ \(0\)\
\-\ had\\:\\ 0\\.04187109910077072\ \(0\)\
\-\ commonly\\:\\ 0\\.04145633238883645\ \(0\)\
\-\ eradication\\:\\ 0\\.041394758984618765\ \(0\)\
\-\ revisions\\:\\ 0\\.041394758984618765\ \(0\)\
\-\ antibiotics\\:\\ 0\\.04127545155343069\ \(0\)\
\-\ metastasis\\:\\ 0\\.041062702041565834\ \(0\)\
\-\ diagnosed\\:\\ 0\\.0405835069187306\ \(0\)\
\-\ adopted\\:\\ 0\\.04029895101489587\ \(0\)\
\-\ exemplifies\\:\\ 0\\.04029895101489587\ \(0\)\
\-\ modern\\:\\ 0\\.04029895101489587\ \(0\)\
\-\ later\\:\\ 0\\.040094771676872934\ \(0\)\
\-\ malignant\\:\\ 0\\.03993711898596797\ \(0\)\
\-\ hpv\\:\\ 0\\.039403610711264254\ \(0\)\
\-\ multidisciplinary\\:\\ 0\\.03864661127077827\ \(0\)\
\-\ atlas\\:\\ 0\\.03864661127077827\ \(0\)\
\-\ is\\:\\ 0\\.03835754977826547\ \(0\)\
\-\ neoplasm\\:\\ 0\\.038245990835982235\ \(0\)\
\-\ exenteration\\:\\ 0\\.03799086852856428\ \(0\)\
\-\ acne\\:\\ 0\\.03799086852856428\ \(0\)\
\-\ cytologic\\:\\ 0\\.03799086852856428\ \(0\)\
\-\ size\\:\\ 0\\.03793499223778751\ \(0\)\
\-\ canthus\\:\\ 0\\.037412462437909744\ \(0\)\
\-\ worldwide\\:\\ 0\\.037412462437909744\ \(0\)\
\-\ demographic\\:\\ 0\\.037412462437909744\ \(0\)\
\-\ opted\\:\\ 0\\.036895060558841376\ \(0\)\
\-\ consumption\\:\\ 0\\.036895060558841376\ \(0\)\
\-\ uncommonly\\:\\ 0\\.036895060558841376\ \(0\)\
\-\ places\\:\\ 0\\.036895060558841376\ \(0\)\
\-\ medial\\:\\ 0\\.03646848467973715\ \(0\)\
\-\ past\\:\\ 0\\.03646848467973715\ \(0\)\
\-\ no\\:\\ 0\\.03643784342989086\ \(0\)\
\-\ immobile\\:\\ 0\\.036427013626675116\ \(0\)\
\-\ nasolacrimal\\:\\ 0\\.036427013626675116\ \(0\)\
\-\ by\\:\\ 0\\.035687645434340026\ \(0\)\
\-\ highest\\:\\ 0\\.035606648456942315\ \(0\)\
\-\ oropharyngeal\\:\\ 0\\.035606648456942315\ \(0\)\
\-\ 06\\:\\ 0\\.035606648456942315\ \(0\)\
\-\ mar\\:\\ 0\\.035606648456942315\ \(0\)\
\-\ medical\\:\\ 0\\.03560657661573589\ \(0\)\
\-\ clinical\\:\\ 0\\.03550645799381901\ \(0\)\
\-\ concerns\\:\\ 0\\.03524272081472378\ \(0\)\
\-\ grown\\:\\ 0\\.03524272081472378\ \(0\)\
\-\ reconstructive\\:\\ 0\\.03524272081472378\ \(0\)\
\-\ james\\:\\ 0\\.03524272081472378\ \(0\)\
\-\ lee\\:\\ 0\\.03524272081472378\ \(0\)\
\-\ 09\\:\\ 0\\.03524272081472378\ \(0\)\
\-\ corner\\:\\ 0\\.034903912285486866\ \(0\)\
\-\ negative\\:\\ 0\\.0346851308551795\ \(0\)\
\-\ seventh\\:\\ 0\\.03458697807250979\ \(0\)\
\-\ beneath\\:\\ 0\\.03458697807250979\ \(0\)\
\-\ aware\\:\\ 0\\.03458697807250979\ \(0\)\
\-\ genetics\\:\\ 0\\.03458697807250979\ \(0\)\
\-\ demonstrated\\:\\ 0\\.03443189081391373\ \(0\)\
\-\ urgent\\:\\ 0\\.034289264141918345\ \(0\)\
\-\ recognition\\:\\ 0\\.034289264141918345\ \(0\)\
\-\ neck\\:\\ 0\\.03427247529277396\ \(0\)\
\-\ appointment\\:\\ 0\\.03400857198185525\ \(0\)\
\-\ clinicians\\:\\ 0\\.03400857198185525\ \(0\)\
\-\ tearing\\:\\ 0\\.03374305997570584\ \(0\)\
\-\ architecture\\:\\ 0\\.03349117010278689\ \(0\)\
\-\ pharynx\\:\\ 0\\.03349117010278689\ \(0\)\
\-\ insidious\\:\\ 0\\.03349117010278689\ \(0\)\
\-\ ma\\:\\ 0\\.03349117010278689\ \(0\)\
\-\ head\\:\\ 0\\.033414960676290094\ \(0\)\
\-\ two\\:\\ 0\\.03327111113032435\ \(0\)\
\-\ lacrimal\\:\\ 0\\.03325157254136927\ \(0\)\
\-\ spared\\:\\ 0\\.03325157254136927\ \(0\)\
\-\ scan\\:\\ 0\\.033239428677814174\ \(0\)\
\-\ concerned\\:\\ 0\\.0328048305271341\ \(0\)\
\-\ presented\\:\\ 0\\.03267101767038319\ \(0\)\
\-\ adjuvant\\:\\ 0\\.03259582979915527\ \(0\)\
\-\ displacing\\:\\ 0\\.03259582979915527\ \(0\)\
\-\ staining\\:\\ 0\\.03259582979915527\ \(0\)\
\-\ uptodate\\:\\ 0\\.03259582979915527\ \(0\)\
\-\ virus\\:\\ 0\\.03220275800088782\ \(0\)\
\-\ lesions\\:\\ 0\\.03217619783250561\ \(0\)\
\-\ an\\:\\ 0\\.032136062205101845\ \(0\)\
\-\ history\\:\\ 0\\.03210759393026841\ \(0\)\
\-\ biopsies\\:\\ 0\\.03183883035866929\ \(0\)\
\-\ overview\\:\\ 0\\.03183883035866929\ \(0\)\
\-\ school\\:\\ 0\\.03166650475171891\ \(0\)\
\-\ dysplastic\\:\\ 0\\.031183087616455295\ \(0\)\
\-\ situ\\:\\ 0\\.031183087616455295\ \(0\)\
\-\ examined\\:\\ 0\\.03103197489726611\ \(0\)\
\-\ visualize\\:\\ 0\\.030885373685863856\ \(0\)\
\-\ correlate\\:\\ 0\\.030885373685863856\ \(0\)\
\-\ brown\\:\\ 0\\.030885373685863856\ \(0\)\
\-\ yellow\\:\\ 0\\.03074302238894639\ \(0\)\
\-\ oropharynx\\:\\ 0\\.030604681525800762\ \(0\)\
\-\ proper\\:\\ 0\\.030604681525800762\ \(0\)\
\-\ physical\\:\\ 0\\.030378423290834042\ \(0\)\
\-\ increased\\:\\ 0\\.030296037112931957\ \(0\)\
\-\ surgery\\:\\ 0\\.030121788572805817\ \(0\)\
\-\ doctor\\:\\ 0\\.0300872796467324\ \(0\)\
\-\ cancers\\:\\ 0\\.0300872796467324\ \(0\)\
\-\ morbidity\\:\\ 0\\.0300872796467324\ \(0\)\
\-\ oncology\\:\\ 0\\.029966019760392648\ \(0\)\
\-\ doing\\:\\ 0\\.029732129086172412\ \(0\)\
\-\ chief\\:\\ 0\\.02961923271456613\ \(0\)\
\-\ associated\\:\\ 0\\.029529747804032048\ \(0\)\
\-\ decade\\:\\ 0\\.029508873556077862\ \(0\)\
\-\ can\\:\\ 0\\.029400514995273692\ \(0\)\
\-\ tumor\\:\\ 0\\.029304694218054927\ \(0\)\
\-\ lump\\:\\ 0\\.029295327917195562\ \(0\)\
\-\ importance\\:\\ 0\\.029295327917195562\ \(0\)\
\-\ individuals\\:\\ 0\\.029295327917195562\ \(0\)\
\-\ abuse\\:\\ 0\\.02919193934310078\ \(0\)\
\-\ social\\:\\ 0\\.029090682644828794\ \(0\)\
\-\ diagnosis\\:\\ 0\\.029043328295610786\ \(0\)\
\-\ completed\\:\\ 0\\.0289914716770095\ \(0\)\
\-\ endoscopy\\:\\ 0\\.0289914716770095\ \(0\)\
\-\ planned\\:\\ 0\\.028705326128400772\ \(0\)\
\-\ lower\\:\\ 0\\.028629196385344283\ \(0\)\
\-\ might\\:\\ 0\\.02861353325244625\ \(0\)\
\-\ fine\\:\\ 0\\.028523424744843234\ \(0\)\
\-\ indicate\\:\\ 0\\.028523424744843234\ \(0\)\
\-\ provide\\:\\ 0\\.02834802124629684\ \(0\)\
\-\ nose\\:\\ 0\\.02834802124629684\ \(0\)\
\-\ consultation\\:\\ 0\\.028262614295664415\ \(0\)\
\-\ exam\\:\\ 0\\.02820336784244403\ \(0\)\
\-\ affecting\\:\\ 0\\.02817866736462969\ \(0\)\
\-\ him\\:\\ 0\\.027856533811960262\ \(0\)\
\-\ combined\\:\\ 0\\.027779197160400802\ \(0\)\
\-\ but\\:\\ 0\\.027704798594660515\ \(0\)\
\-\ mortality\\:\\ 0\\.027554236795753223\ \(0\)\
\-\ growing\\:\\ 0\\.027481483229809364\ \(0\)\
\-\ managed\\:\\ 0\\.027409791797725097\ \(0\)\
\-\ multiple\\:\\ 0\\.027403391584828213\ \(0\)\
\-\ surgical\\:\\ 0\\.027230320115052938\ \(0\)\
\-\ true\\:\\ 0\\.027200791069746273\ \(0\)\
\-\ trachea\\:\\ 0\\.02713305515610436\ \(0\)\
\-\ requires\\:\\ 0\\.02713305515610436\ \(0\)\
\-\ well\\:\\ 0\\.02712792247064558\ \(0\)\
\-\ systems\\:\\ 0\\.02706624084814793\ \(0\)\
\-\ mucosa\\:\\ 0\\.027000323403654988\ \(0\)\
\-\ reduced\\:\\ 0\\.026871085000725634\ \(0\)\
\-\ lesion\\:\\ 0\\.026859969230767614\ \(0\)\
\-\ determined\\:\\ 0\\.026683389190677906\ \(0\)\
\-\ duty\\:\\ 0\\.026562129304338156\ \(0\)\
\-\ cns\\:\\ 0\\.026159852675108224\ \(0\)\
\-\ obstructive\\:\\ 0\\.026050719830992837\ \(0\)\
\-\ needle\\:\\ 0\\.025997049615025115\ \(0\)\
\-\ orbit\\:\\ 0\\.025943959628972488\ \(0\)\
\-\ order\\:\\ 0\\.02589143746114107\ \(0\)\
\-\ overall\\:\\ 0\\.025737159562415516\ \(0\)\
\-\ papilloma\\:\\ 0\\.0256867921887743\ \(0\)\
\-\ has\\:\\ 0\\.025590909521862014\ \(0\)\
\-\ nasal\\:\\ 0\\.025538717376196493\ \(0\)\
\-\ which\\:\\ 0\\.025475445423354177\ \(0\)\
\-\ majority\\:\\ 0\\.02544242456784547\ \(0\)\
\-\ firm\\:\\ 0\\.02539497708877884\ \(0\)\
\-\ erythema\\:\\ 0\\.025347983659537388\ \(0\)\
\-\ complaining\\:\\ 0\\.025347983659537388\ \(0\)\
\-\ close\\:\\ 0\\.025347983659537388\ \(0\)\
\-\ denied\\:\\ 0\\.02530143567234628\ \(0\)\
\-\ suspicious\\:\\ 0\\.025031049446560306\ \(0\)\
\-\ sac\\:\\ 0\\.02494413079024235\ \(0\)\
\-\ painful\\:\\ 0\\.0247747769085752\ \(0\)\
\-\ direct\\:\\ 0\\.02469224091732339\ \(0\)\
\-\ prognosis\\:\\ 0\\.024651487356622478\ \(0\)\
\-\ orbital\\:\\ 0\\.024570981030983645\ \(0\)\
\-\ degree\\:\\ 0\\.02449177325123211\ \(0\)\
\-\ aspiration\\:\\ 0\\.02449177325123211\ \(0\)\
\-\ that\\:\\ 0\\.024313054852319143\ \(0\)\
\-\ complaint\\:\\ 0\\.02426153846840029\ \(0\)\
\-\ subtle\\:\\ 0\\.024150346339698738\ \(0\)\
\-\ duct\\:\\ 0\\.024113834826668862\ \(0\)\
\-\ incidence\\:\\ 0\\.024113834826668862\ \(0\)\
\-\ require\\:\\ 0\\.02407759277375487\ \(0\)\
\-\ those\\:\\ 0\\.02397044432206988\ \(0\)\
\-\ overlying\\:\\ 0\\.023865583913442675\ \(0\)\
\-\ few\\:\\ 0\\.023762915869887026\ \(0\)\
\-\ healthy\\:\\ 0\\.023762915869887026\ \(0\)\
\-\ dermoid\\:\\ 0\\.023662350392093436\ \(0\)\
\-\ numerous\\:\\ 0\\.023662350392093436\ \(0\)\
\-\ so\\:\\ 0\\.023563803087479518\ \(0\)\
\-\ disease\\:\\ 0\\.023517600566127717\ \(0\)\
\-\ worse\\:\\ 0\\.023467194544671145\ \(0\)\
\-\ necessary\\:\\ 0\\.023435409476549613\ \(0\)\
\-\ represent\\:\\ 0\\.02331028739899177\ \(0\)\
\-\ difficult\\:\\ 0\\.023248901901184615\ \(0\)\
\-\ under\\:\\ 0\\.02318827426840165\ \(0\)\
\-\ recurrence\\:\\ 0\\.023128386015434235\ \(0\)\
\-\ young\\:\\ 0\\.023098713563340412\ \(0\)\
\-\ frequently\\:\\ 0\\.023069219325246745\ \(0\)\
\-\ review\\:\\ 0\\.023069219325246745\ \(0\)\
\-\ indicated\\:\\ 0\\.023039901173205795\ \(0\)\
\-\ intermittent\\:\\ 0\\.022895879828361786\ \(0\)\
\-\ near\\:\\ 0\\.02281145180245715\ \(0\)\
\-\ good\\:\\ 0\\.022783628635220685\ \(0\)\
\-\ be\\:\\ 0\\.022727388670565497\ \(0\)\
\-\ mildly\\:\\ 0\\.022619920946622414\ \(0\)\
\-\ inflammation\\:\\ 0\\.02251373787186571\ \(0\)\
\-\ references\\:\\ 0\\.022333269106361027\ \(0\)\
\-\ al\\:\\ 0\\.022257910452927424\ \(0\)\
\-\ excision\\:\\ 0\\.02208644450040036\ \(0\)\
\-\ family\\:\\ 0\\.022038534111790974\ \(0\)\
\-\ et\\:\\ 0\\.021944093203482902\ \(0\)\
\-\ results\\:\\ 0\\.021828540204340535\ \(0\)\
\-\ 16\\:\\ 0\\.021828540204340535\ \(0\)\
\-\ deep\\:\\ 0\\.021805752340337266\ \(0\)\
\-\ free\\:\\ 0\\.021805752340337266\ \(0\)\
\-\ reports\\:\\ 0\\.021783069732432013\ \(0\)\
\-\ made\\:\\ 0\\.021605284674245988\ \(0\)\
\-\ partial\\:\\ 0\\.02158350736192458\ \(0\)\
\-\ currently\\:\\ 0\\.02151874893935835\ \(0\)\
\-\ specific\\:\\ 0\\.021227346249682737\ \(0\)\
\-\ process\\:\\ 0\\.02100993233499531\ \(0\)\
\-\ pattern\\:\\ 0\\.02091420267825294\ \(0\)\
\-\ active\\:\\ 0\\.02080173724656889\ \(0\)\
\-\ management\\:\\ 0\\.02069178991045335\ \(0\)\
\-\ tender\\:\\ 0\\.02047901543612676\ \(0\)\
\-\ clear\\:\\ 0\\.020308485250272738\ \(0\)\
\-\ involvement\\:\\ 0\\.02027507848279781\ \(0\)\
\-\ early\\:\\ 0\\.020192542491546003\ \(0\)\
\-\ reported\\:\\ 0\\.020176200460222934\ \(0\)\
\-\ did\\:\\ 0\\.020095296227045846\ \(0\)\
\-\ including\\:\\ 0\\.020047385838436467\ \(0\)\
\-\ care\\:\\ 0\\.020015703303505196\ \(0\)\
\-\ required\\:\\ 0\\.01999993835936984\ \(0\)\
\-\ otherwise\\:\\ 0\\.019968559492983984\ \(0\)\
\-\ 24\\:\\ 0\\.019860286032501447\ \(0\)\
\-\ extension\\:\\ 0\\.019829784220896443\ \(0\)\
\-\ palpable\\:\\ 0\\.019680053845384415\ \(0\)\
\-\ because\\:\\ 0\\.019577894347977486\ \(0\)\
\-\ status\\:\\ 0\\.019549092060833346\ \(0\)\
\-\ being\\:\\ 0\\.019520457718008942\ \(0\)\
\-\ or\\:\\ 0\\.019490345101124983\ \(0\)\
\-\ sign\\:\\ 0\\.019393630057965412\ \(0\)\
\-\ underwent\\:\\ 0\\.019297202187914392\ \(0\)\
\-\ presentation\\:\\ 0\\.01928358005468394\ \(0\)\
\-\ although\\:\\ 0\\.019070613311933476\ \(0\)\
\-\ cases\\:\\ 0\\.018841571889115793\ \(0\)\
\-\ three\\:\\ 0\\.018804415778333982\ \(0\)\
\-\ initial\\:\\ 0\\.018792092620347364\ \(0\)\
\-\ unremarkable\\:\\ 0\\.018779800308846028\ \(0\)\
\-\ showed\\:\\ 0\\.018658540422506278\ \(0\)\
\-\ space\\:\\ 0\\.018646577503360833\ \(0\)\
\-\ positive\\:\\ 0\\.01845903105008194\ \(0\)\
\-\ revealed\\:\\ 0\\.018367877140478023\ \(0\)\
\-\ often\\:\\ 0\\.01827838444275489\ \(0\)\
\-\ should\\:\\ 0\\.01827838444275489\ \(0\)\
\-\ further\\:\\ 0\\.0182452407226981\ \(0\)\
\-\ examination\\:\\ 0\\.017925554603859885\ \(0\)\
\-\ during\\:\\ 0\\.017743278079865917\ \(0\)\
\-\ tenderness\\:\\ 0\\.01756752579223733\ \(0\)\
\-\ yo\\:\\ 0\\.017500841098952783\ \(0\)\
\-\ primary\\:\\ 0\\.017224882217213414\ \(0\)\
\-\ month\\:\\ 0\\.01704054190841047\ \(0\)\
\-\ infection\\:\\ 0\\.016921383787940888\ \(0\)\
\-\ on\\:\\ 0\\.016920724529526587\ \(0\)\
\-\ following\\:\\ 0\\.016805048631294173\ \(0\)\
\-\ all\\:\\ 0\\.016675383649500698\ \(0\)\
\-\ chronic\\:\\ 0\\.01662762856444063\ \(0\)\
\-\ months\\:\\ 0\\.01630574646602665\ \(0\)\
\-\ cyst\\:\\ 0\\.016159581632274364\ \(0\)\
\-\ mild\\:\\ 0\\.015879689598629447\ \(0\)\
\-\ who\\:\\ 0\\.01584579867128833\ \(0\)\
\-\ these\\:\\ 0\\.01581885333136301\ \(0\)\
\-\ over\\:\\ 0\\.01557637751888282\ \(0\)\
\-\ symptoms\\:\\ 0\\.015327046008033019\ \(0\)\
\-\ man\\:\\ 0\\.014830351883814083\ \(0\)\
\-\ without\\:\\ 0\\.014775726449815596\ \(0\)\
\-\ tissue\\:\\ 0\\.014694910980091113\ \(0\)\
\-\ other\\:\\ 0\\.014547524006829704\ \(0\)\
\-\ mri\\:\\ 0\\.01437931285088793\ \(0\)\
\-\ present\\:\\ 0\\.014374304409983954\ \(0\)\
\-\ it\\:\\ 0\\.014339387623811426\ \(0\)\
\-\ may\\:\\ 0\\.014096950642898292\ \(0\)\
\-\ demonstrates\\:\\ 0\\.014073352443328099\ \(0\)\
\-\ large\\:\\ 0\\.014035829617937062\ \(0\)\
\-\ after\\:\\ 0\\.013589493923070045\ \(0\)\
\-\ also\\:\\ 0\\.013176442951032971\ \(0\)\
\-\ within\\:\\ 0\\.012901856009972163\ \(0\)\
\-\ male\\:\\ 0\\.012472399505277064\ \(0\)\
\-\ normal\\:\\ 0\\.011437459810589117\ \(0\)\
\-\ are\\:\\ 0\\.010629603477709798\ \(0\)\
\-\ pain\\:\\ 0\\.01002402950683698\ \(0\)\
\-\ year\\:\\ 0\\.008633009590939471\ \(0\)\
\-\ old\\:\\ 0\\.008290677597733413\ \(0\)\
